Table 1. Summary of NGS results from NIPGS, TE and WB samples obtained from the same blastocyst.

Sample Number	TE biopsy*	NIPGS	WB
1	XX; +18	XX; +18	XX; +18
2	XX; +20	XX; +20	XX; +20
3	XX; -10, +21q21.2–22.3 (21.05Mb)	XX; normal	XX; -10
4	XY; +4, +9q	XY; +4	XY; +4
5	NA	XX; normal	XX; normal
6	XX; +22	XX; +22	XX; +22
7	NA	XX; normal	XX; normal
8	NA	68, XXY; -21	68, XXY; -21
9	NA	XX; +22	XX; +22
10	XY; +12	XY; +5q (70%)	XY; normal
11	XX; +22	XX; normal	XX; normal
12	XY; +19	XY; +19	XY; +19
13	XX; -22	XX; -22	XX; -22
14	XY; -18; -21	XY; -18; -21	XY; -18; -21
15	XY; +22	XY; +22; mosaic -8 (40%)	XY; +22
16	XY; +12q21.1–24.33 (62.08Mb)	XY; +12q21.1–24.33 (62.08Mb)	XY; normal
17	XY; +15, +16	XY; +15, +16	XY; +15, +16
18	XY; -16	XY; -16	XY; -16
19	XX; -16	XX; -16	XX; -16
20	XX; +17	XX; +17	XX; +17
21	XY; +15	XY; +15	XY; +15
22	XY; +11, mosaic -21 (50%)	XY; +11	XY; +11
23	XY; +19	XY; +19, mosaic -5 (30%)	XY; +19
24	XX; +16	XX; +7, +16	XX; +16
25	XY; -11, +12pter-q14 (64.65Mb)	XY;-11, +12pter-q14 (63.48Mb)	XY;-11, +12pter-q14 (63.48Mb)
26	XX; +9, -17	XX; +9, -17	XX; +9, -17
27	XY; -4, +22	XY; -4, +22	XY; -4, +22
28	XY; -6p 25.3–12.1 (53.69Mb)	XY; -6p 25.3–12.1 (53.69Mb)	XY; -6p 25.3–21`.2 (37.15Mb)

NA = not available

TE = Trophectoderm

NIPGS = Noninvasive preimplantation genetic screening

WB = Whole blastocyst

* Clinical PGT-A results from TE biopsy perform prior initial embryo vitrification.